1. Home
  2. MGNI vs LMAT Comparison

MGNI vs LMAT Comparison

Compare MGNI & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGNI
  • LMAT
  • Stock Information
  • Founded
  • MGNI 2007
  • LMAT 1983
  • Country
  • MGNI United States
  • LMAT United States
  • Employees
  • MGNI N/A
  • LMAT N/A
  • Industry
  • MGNI Computer Software: Programming Data Processing
  • LMAT Medical/Dental Instruments
  • Sector
  • MGNI Technology
  • LMAT Health Care
  • Exchange
  • MGNI Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • MGNI 1.7B
  • LMAT 2.0B
  • IPO Year
  • MGNI N/A
  • LMAT 2006
  • Fundamental
  • Price
  • MGNI $12.94
  • LMAT $89.08
  • Analyst Decision
  • MGNI Strong Buy
  • LMAT Buy
  • Analyst Count
  • MGNI 11
  • LMAT 6
  • Target Price
  • MGNI $16.95
  • LMAT $92.60
  • AVG Volume (30 Days)
  • MGNI 1.3M
  • LMAT 98.3K
  • Earning Date
  • MGNI 11-07-2024
  • LMAT 10-31-2024
  • Dividend Yield
  • MGNI N/A
  • LMAT 0.72%
  • EPS Growth
  • MGNI N/A
  • LMAT 47.83
  • EPS
  • MGNI N/A
  • LMAT 1.67
  • Revenue
  • MGNI $649,216,000.00
  • LMAT $205,621,000.00
  • Revenue This Year
  • MGNI $0.26
  • LMAT $15.01
  • Revenue Next Year
  • MGNI $10.75
  • LMAT $9.07
  • P/E Ratio
  • MGNI N/A
  • LMAT $54.11
  • Revenue Growth
  • MGNI 7.50
  • LMAT 16.06
  • 52 Week Low
  • MGNI $6.46
  • LMAT $45.96
  • 52 Week High
  • MGNI $15.92
  • LMAT $93.32
  • Technical
  • Relative Strength Index (RSI)
  • MGNI 54.59
  • LMAT 55.00
  • Support Level
  • MGNI $12.35
  • LMAT $84.69
  • Resistance Level
  • MGNI $13.11
  • LMAT $92.84
  • Average True Range (ATR)
  • MGNI 0.42
  • LMAT 2.05
  • MACD
  • MGNI 0.11
  • LMAT -0.07
  • Stochastic Oscillator
  • MGNI 63.58
  • LMAT 75.21

About MGNI Magnite Inc.

Magnite is one of the largest supply-side platform providers, or SSP, in online advertising. The firm was previously named The Rubicon Project (an online ad exchange) and became Magnite after merging with Telaria (an SSP focused mainly on streaming video providers) in 2020. The firm also purchased another of the leading SSPs within the CTV market, SpotX, in 2021 for $1.2 billion, cementing its long-term focus on grabbing market share in this area. The firm generates nearly 45% of its revenue from the programmatic sale of CTV ad inventory, 35% from mobile online sites and apps, and the remaining from websites accessed via computer.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Share on Social Networks: